"it's a very exciting time," klugman said. "this is exactly where we would like prenatal diagnosis to go -- to be able to act on it.".-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..

.

another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict..

"we are glad our concerns have been addressed by the coroner's office but the western trust has a lot to answer for...

.